Clinical Trial Update: RIGHT: Rhythm ID Going Head-to-Head Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Rhythm ID for tachycardia has completed with results posted in 2011 by Boston Scientific.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachycardia

Drugs mentioned

• Rhythm ID

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Tachycardia | Phase 4 | Status: COMPLETED | Results posted: 2011-12-26